BBS-Bioactive Bone Substitutes Oyj - ESG Rating & Company Profile powered by AI
If you work at BBS-Bioactive Bone Substitutes Oyj and you would like to licence your ESG aseessment, please get in touch. This dashboard includes a questions and answers table for BBS-Bioactive Bone Substitutes Oyj. Check the bottom of the page for potential risks for BBS-Bioactive Bone Substitutes Oyj based on industry, geography and marketcap.
BBS-Bioactive Bone Substitutes Oyj in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 8.0, social score of 2.7 and governance score of 5.3.
5.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
645 | Biomm SA | 5.4 | High |
645 | Tiziana Life Sciences PLC | 5.4 | High |
658 | BBS-Bioactive Bone Substitutes Oyj | 5.3 | High |
658 | Cellmid Ltd | 5.3 | High |
658 | Bio-Techne Corp | 5.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does BBS-Bioactive Bone Substitutes Oyj have an accelerator or VC vehicle to help deliver innovation?
Does BBS-Bioactive Bone Substitutes Oyj disclose current and historical energy intensity?
Does BBS-Bioactive Bone Substitutes Oyj report the average age of the workforce?
Does BBS-Bioactive Bone Substitutes Oyj reference operational or capital allocation in relation to climate change?
Does BBS-Bioactive Bone Substitutes Oyj disclose its ethnicity pay gap?
Does BBS-Bioactive Bone Substitutes Oyj disclose cybersecurity risks?
Does BBS-Bioactive Bone Substitutes Oyj use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does BBS-Bioactive Bone Substitutes Oyj offer flexible work?
Does BBS-Bioactive Bone Substitutes Oyj have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does BBS-Bioactive Bone Substitutes Oyj disclose the number of employees in R&D functions?
Does BBS-Bioactive Bone Substitutes Oyj plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does BBS-Bioactive Bone Substitutes Oyj conduct supply chain audits?
Does BBS-Bioactive Bone Substitutes Oyj disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does BBS-Bioactive Bone Substitutes Oyj conduct 360 degree staff reviews?
Does BBS-Bioactive Bone Substitutes Oyj disclose the individual responsible for D&I?
Does BBS-Bioactive Bone Substitutes Oyj disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does BBS-Bioactive Bone Substitutes Oyj disclose current and / or historical scope 2 emissions?
Does BBS-Bioactive Bone Substitutes Oyj disclose water use targets?
Does BBS-Bioactive Bone Substitutes Oyj have careers partnerships with academic institutions?
Did BBS-Bioactive Bone Substitutes Oyj have a product recall in the last two years?
Does BBS-Bioactive Bone Substitutes Oyj disclose incidents of discrimination?
Does BBS-Bioactive Bone Substitutes Oyj allow for Work Councils/Collective Agreements to be formed?
Has BBS-Bioactive Bone Substitutes Oyj issued a profit warning in the past 24 months?
Does BBS-Bioactive Bone Substitutes Oyj disclose parental leave metrics?
Does BBS-Bioactive Bone Substitutes Oyj disclose climate scenario or pathway analysis?
Does BBS-Bioactive Bone Substitutes Oyj disclose current and / or historical scope 1 emissions?
Does BBS-Bioactive Bone Substitutes Oyj explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does BBS-Bioactive Bone Substitutes Oyj disclose the pay ratio of women to men?
Does BBS-Bioactive Bone Substitutes Oyj support suppliers with sustainability related research and development?
Does BBS-Bioactive Bone Substitutes Oyj disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does BBS-Bioactive Bone Substitutes Oyj reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is BBS-Bioactive Bone Substitutes Oyj involved in embryonic stem cell research?
Does BBS-Bioactive Bone Substitutes Oyj disclose GHG and Air Emissions intensity?
Does BBS-Bioactive Bone Substitutes Oyj disclose its waste policy?
Does BBS-Bioactive Bone Substitutes Oyj report according to TCFD requirements?
Does BBS-Bioactive Bone Substitutes Oyj plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does BBS-Bioactive Bone Substitutes Oyj disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does BBS-Bioactive Bone Substitutes Oyj disclose energy use targets?
Does BBS-Bioactive Bone Substitutes Oyj disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does BBS-Bioactive Bone Substitutes Oyj have a policy relating to cyber security?
Have a different question?
Potential Risks for BBS-Bioactive Bone Substitutes Oyj
These potential risks are based on the size, segment and geographies of the company.